Nicotine Metabolism in Young Adult Daily Menthol and Nonmenthol Smokers

作者: Pebbles Fagan , Pallav Pokhrel , Thaddeus A. Herzog , Ian S. Pagano , Adrian A. Franke

DOI: 10.1093/NTR/NTV109

关键词:

摘要: Introduction Menthol cigarette smoking may increase the risk for tobacco smoke exposure and inhibit nicotine metabolism in liver. Nicotine is primarily mediated by enzyme CYP2A6 metabolite ratio (NMR = trans 3' hydroxycotinine/cotinine) a phenotypic proxy activity. No studies have examined differences this biomarker among young adult daily menthol nonmenthol smokers. This study compares biomarkers of Methods Saliva cotinine carbon monoxide were measured multiethnic sample smokers aged 18-35 (n 186). Nicotine, cotinine, cotinine/cigarette per day ratio, hydroxycotinine, NMR, expired compared. Results The geometric means nicotine, did not significantly differ between NMR was lower compared with after adjusting race/ethnicity, gender, body mass index, smoked (0.19 vs. 0.24, P .03). White had higher cotinine/cigarettes than white adjusted model. unadjusted model (0.24 0.31, .05) remained marginally significant (0.28 0.34, .06). We observe these Native Hawaiians Filipinos. Conclusions Young slower rates Studies are needed to determine utility cessation treatment assignments.

参考文章(53)
Dennis R. Trinidad, Eliseo J. Pérez-Stable, Karen Messer, Martha M. White, John P. Pierce, Menthol cigarettes and smoking cessation among racial/ethnic groups in the United States Addiction. ,vol. 105, pp. 84- 94 ,(2010) , 10.1111/J.1360-0443.2010.03187.X
Li-Shiun Chen, A. Joseph Bloom, Timothy B. Baker, Stevens S. Smith, Megan E. Piper, Maribel Martinez, Nancy Saccone, Dorothy Hatsukami, Alison Goate, Laura Bierut, Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6). Addiction. ,vol. 109, pp. 128- 137 ,(2014) , 10.1111/ADD.12353
R F Tyndale, E M Sellers, E S Messina, A Major Role for CYP2A6 in Nicotine C-Oxidation by Human Liver Microsomes Journal of Pharmacology and Experimental Therapeutics. ,vol. 282, pp. 1608- 1614 ,(1997)
K.-I. Nunoya, Y. Funae, Y. Kuroiwa, T. Yokoi, K. Nagashima, K. Inoue, T. Yamamoto, T. Kamataki, N. Shimada, M. Nakajima, Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes. Journal of Pharmacology and Experimental Therapeutics. ,vol. 277, pp. 1010- 1015 ,(1996)
James M. MacDougall, Keith Fandrick, Xiaodong Zhang, Scott V. Serafin, John R. Cashman, Inhibition of human liver microsomal (S)-nicotine oxidation by (-)-menthol and analogues. Chemical Research in Toxicology. ,vol. 16, pp. 988- 993 ,(2003) , 10.1021/TX0340551
Jill C. Mwenifumbo, Nael Al Koudsi, Man Ki Ho, Qian Zhou, Ewa B. Hoffmann, Edward M. Sellers, Rachel F. Tyndale, Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent. Human Mutation. ,vol. 29, pp. 679- 688 ,(2008) , 10.1002/HUMU.20698
John E. Lewis, Luis Espinoza, Asthana Deshratan, María José Míguez-Burbano, Mayra Vargas, Clery Quiros, Menthol cigarettes and the cardiovascular risks of people living with HIV Journal of the Association of Nurses in AIDS Care. ,vol. 25, pp. 427- 435 ,(2014) , 10.1016/J.JANA.2014.01.006
Geoffrey Ferris Wayne, Gregory Connolly, Application, function, and effects of menthol in cigarettes: a survey of tobacco industry documents. Nicotine & Tobacco Research. ,vol. 6, pp. 43- 54 ,(2004) , 10.1080/14622203310001649513
Babalola Faseru, Nicole L. Nollen, Matthew S. Mayo, Ron Krebill, Won S. Choi, Neal L. Benowitz, Rachel F. Tyndale, Kolawole S. Okuyemi, Jasjit S. Ahluwalia, Lisa Sanderson Cox, Predictors of cessation in African American light smokers enrolled in a bupropion clinical trial Addictive Behaviors. ,vol. 38, pp. 1796- 1803 ,(2013) , 10.1016/J.ADDBEH.2012.11.010